TORONTO (PRWEB) June 15, 2020
Randomised trials are challenging to conduct, and even when well designed, post-randomisation events will occur during follow-up, which affect the interpretation of results. For instance, patients may stop taking their allocated treatment and/or withdraw from the study, they may receive rescue medication, or they may die before the outcome can be measured. These issues can pose a challenge to the interpretation of the trial and are often the source of debate around the validity of results. In November 2019, ICH issued an addendum to ICH E9 (R1) entitled Estimands and Sensitivity Analyses in Clinical Trials to address such issues.
Join Alan Phillips, PhD, BSc, CStat, Senior Director Biostatistics, ICON Clinical Research and Tim Clark, Dip. Stat., PhD, Vice-President, Clinical Sciences, ICON Clinical Research GmbH in a live webinar on Monday, July 6, 2020 at 9am EDT (2pm BST/UK).
For more information or to register for this event, visit Bringing Clarity and Focus to Research Questions: ICH E9 (R1) Estimands and Sensitivity Analyses in Clinical Trials.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/